Member Info for 1pencil

Does anyone remember that chap talking about airline grub, snacks and ready meals - kind of made sense at the time as Iceland (the shop, not the country) were just starting with meals.

Nothing since tho'

Big F1 weekend ahead,

Race Weekend

FORMULA 1 ABU DHABI GRAND PRIX 2023

https://www.williamsf1.com/grand-prix-experience/7db9db7e-ca39-46bf-9ecf-af53e9b8e1ee/abu-dhabi-2023

Around 8% of the issued share cap traded, should see some movement notifications TR1's

Some largish trades just after 3pm, price improved following these prints.

Might be last of overhang..

London stock exchange has become an offshoot of New York, volumes are terrible until US opens in addition, SFOR has few regular UK institutions onboard.

Upside to all of this of course is almost weekly bids for UK companies.

Nige, data has some delays which vary

Third Templeton account popped up, shares static

Removing listing fees at this level makes even more sense. Paying out circ *£450k per year is such a drain on resources and much better spent on the business itself imo.

I suspect the main hurdle for a merger is the share price, many large investors are in higher up 100p mark or higher, entertaining a low offer may prove unpalatable.

*see SPO RNS for approximate costings

This was my post from a week or so ago, has some useful figured for comparison, f/y 2022 revenue came in at $11,767 so if we assume modest growth round up 2023 to $12m.

Share price at 3.5p puts market cap under £12m GBP

______________________________________________

What are investors thoughts on H2 this year Sept IMC Q & A session was interesting, Jeff's sounded pretty confident when quizzed on figure need to for f/y.

H1 $5.6m which equated to 1% increase on 2022 H1, this leaves a whopping $10.3m for H2 to achieve f/y $15.9m guidance.

H2 - 2022 came in at $6.3m so adopting a more cautious approach I would suggest in the region of $8m is more realistic, therefore f/y 2023 would come in at $13.6m.

Even if they roll over some of the revenue into 2024 it would still equate to a very reasonable 15% growth on 2022 numbers.

I thought H2 figures were unlikely but not such a haircut, especially alter managements upbeat investor presentation in Sept.

It really needs someone with clout and reach to takeover, economies of scale are key here.

Marshall Wace have also closed out their long on WPP, purchased 56,521ADR's in June around 850GBP sold end Sept 725p level or thereabouts.

https://fintel.io/so/us/wpp/marshall-wace-llp

Https://fintel.io/so/gb/sfor/third-avenue-variable-series-trust

Bit puzzled as to where the shares are coming from, data on this link is delayed but fairly accurate - not showing much in the way of sales or buying.

https://fintel.io/so/gb/docs

Bit of indecisiveness on my part, not sure whether to wait for half year results but on balance decided the risk of a move upwards is greater than potential disappointment which would hopefully be temporary anyway.

There's clearly a seller feeding the share repurchases, if this stops then the market could be quite thin.

Funds bet on ‘cheapness’ history, Beijing policy spark to reverse US$140 billion rout in Chinese stocks

Valuations of MSCI China Index stocks have slipped back to level last seen in late 2018, from where the market rallied: Cambridge Associates

Cambridge Associates has peers Franklin Templeton and abrdn in the bullish camp

https://www.scmp.com/business/markets/article/3241345/funds-bet-cheapness-history-beijing-policy-spark-reverse-us140-billion-rout-chinese-stocks

Good time to be invested in China right now imo, not only is the economic situation improving but diplomatic relations between China/USA are back on a cooperative footing.

Analysts already tipping their selection of Chinese companies.

Roche steps up efforts to tap potential of China's healthcare market

https://www.chinadaily.com.cn/a/202311/20/WS655ad49aa31090682a5ef154.html

Might get something in this weeks Autumn statement, tax incentives for pension funds to return UK focus, also ISA's.

One of the biggest changes (if they ever get around to it) merging the two indexes, at the moment most UK funds cannot buy THG or SFOR with a Standard listing.

BrokeNSmoke, well earned thumbs up, lol

Low volume, waiting for US to open - London markets devoid of capital

Link

https://www.wilburellisagribusiness.com/plant-health-care-and-wilbur-ellis-agribusiness-enter-into-joint-development-agreement-for-pretec-products/

Spent some time going through the archives looking at possible valuation models, Wilbur-Ellis agreement stands out as it includes figures for PREtec:

Nov 20

"This agreement represents an important validation of the commercial value of PREtec as we move to the first product launches. After more than six years and over $20m invested, the benefits of PREtec peptide products will soon be widely available to growers in the U.S. and elsewhere.”

May 23 annual report

"The Company has invested $30 million in its exciting new technology, the PREtec platform"

In the three years they have been working together PHC spent another $10m, yet todays market cap sits at just under £20m.

From the above link:

"Wilbur-Ellis has been working with our Employ brand (Harpin αβ) for many years and has significantly increased sales since being appointed exclusive distributor for U.S. specialty crops in 2019. They are the ideal partner for us to work with to develop a series of PREtec products in U.S. specialty crops over the coming years"

That was three years ago, since then the relationship has developed further.

6 Alex Albon - Williams

7 Logan Sargeant - Williams

The increase in share price is likely down to headline inflation data, this in turn prompted two THG tracker funds to rejiggle this week increasing weighting for Consumer Discretionary.

Goliath $100b iShares Core MSCI EAFE ETF

from 4th, to 3rd

https://www.ishares.com/uk/professional/en/products/244049/ishares-core-msci-eafe-etf

Smaller iShares MSCI EAFE Small-Cap ETF

from 3rd to 2nd

https://www.ishares.com/us/products/239627/ishares-msci-eafe-smallcap-etf

If these guys have shifted you can bet others have too.

Cavallo Ventures, VC arm of Wilbur Ellis

https://www.cavallovc.com/